Its ability to develop spontaneous colitis due to a point mutation in the Muc2 gene, leading to epithelial barrier dysfunction, highlights the critical role of barrier damage in triggering inflammation, making it a valuable tool for studying UC progression and potential therapy (21, 22). This evidence concerns the gene MUC2 and colitis.